Cancer
Childhood Solid Neoplasm
CI-CAN-00000138Explore in graph →
PediatricNon-malignant22 active trials
- NCIt
- C9107
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000138Explore in graph →
Clinical trials
215 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02444884 | MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors | completed | Phase 1 | 54 | Children's Oncology GroupNETWORK | 0 | Feb 9, 2016 | clinicaltrials |
| NCT01748721 | MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Jan 8, 2016 | clinicaltrials |
| NCT02533895 |
| Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood |
| completed |
| Phase 1 |
| 67 |
| Activartis BiotechINDUSTRY |
| 1 |
| Dec 29, 2015 |
| clinicaltrials |
| NCT00890435 | Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial | completed | — | 53 | Children's Oncology GroupNETWORK | 0 | Oct 21, 2015 | clinicaltrials |
| NCT01725191 | Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 2 | Jul 2, 2015 | clinicaltrials |
| NCT00018967 | Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate | completed | N/A | 10 | National Cancer Institute (NCI)NIH | 4 | Apr 30, 2015 | clinicaltrials |
| NCT00020150 | Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00021216 | Bortezomib in Treating Children With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01853345 | iCAT for Recurrent/Refractory/HR Solid Tumors | completed | — | 101 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 10, 2015 | clinicaltrials |
| NCT01164163 | INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease | completed | Phase 1 | 49 | Children's Oncology GroupNETWORK | 1 | Oct 23, 2014 | clinicaltrials |
| NCT00357500 | Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | completed | Phase 2 | 101 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 1, 2014 | clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT00107458 | Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors | completed | Phase 1 | 26 | Children's Oncology GroupNETWORK | 2 | Aug 7, 2014 | clinicaltrials |
| NCT00003070 | Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | completed | Phase 3 | 13 | Children's Oncology GroupNETWORK | 3 | Aug 5, 2014 | clinicaltrials |
| NCT00002621 | Interferon Alfa in Treating Children With HIV-Related Cancer | completed | Phase 2 | 8 | Children's Oncology GroupNETWORK | 4 | Jul 24, 2014 | clinicaltrials |
| NCT00609141 | IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00217412 | Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00104962 | Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01240538 | Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 26 | National Cancer Institute (NCI)NIH | 2 | May 13, 2014 | clinicaltrials |
| NCT00008424 | Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants | completed | Phase 1 | 7 | Children's Oncology GroupNETWORK | 3 | May 5, 2014 | clinicaltrials |
| NCT00880282 | Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 2 | Apr 29, 2014 | clinicaltrials |
| NCT01231919 | MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 2 | Apr 29, 2014 | clinicaltrials |
| NCT01141244 | Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 72 | National Cancer Institute (NCI)NIH | 2 | Apr 10, 2014 | clinicaltrials |
| NCT00112996 | Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer | completed | Phase 3 | 244 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 8, 2014 | clinicaltrials |
| NCT00622414 | Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00006095 | Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | 20 | Children's Oncology GroupNETWORK | 2 | Feb 21, 2014 | clinicaltrials |
| NCT00006463 | Ecteinascidin 743 in Treating Children With Refractory Solid Tumors | completed | Phase 1 | 13 | Children's Oncology GroupNETWORK | 3 | Feb 21, 2014 | clinicaltrials |
| NCT00070473 | Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors | completed | Phase 1 | 33 | Children's Oncology GroupNETWORK | 2 | Feb 20, 2014 | clinicaltrials |
| NCT00458731 | Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma | completed | Phase 1 | 57 | National Cancer Institute (NCI)NIH | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00002485 | Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer | completed | — | 359 | Children's Oncology GroupNETWORK | 4 | Feb 14, 2014 | clinicaltrials |
| NCT00003739 | Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy | completed | Phase 3 | 67 | Children's Oncology GroupNETWORK | 7 | Feb 14, 2014 | clinicaltrials |
| NCT00066248 | Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment | completed | Phase 2 | 70 | University of South FloridaOTHER | 3 | Feb 3, 2014 | clinicaltrials |
| NCT01273090 | Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma | completed | Phase 1 | 34 | Children's Oncology GroupNETWORK | 2 | Jan 30, 2014 | clinicaltrials |
| NCT00387920 | Sunitinib in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 2 | Jan 28, 2014 | clinicaltrials |
| NCT00075634 | Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00929903 | Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00005881 | Quality of Life in Children Treated for Cancer | completed | — | 538 | Children's Oncology GroupNETWORK | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00002543 | Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | completed | Phase 1 | 3 | Medical College of WisconsinOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00112645 | Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 10 | Milton S. Hershey Medical CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004919 | Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00012181 | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00994500 | Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00433394 | Registration and Informed Consent Study for the Childhood Cancer Research Network | completed | N/A | 2,242 | Children's Oncology GroupNETWORK | 2 | Jun 27, 2013 | clinicaltrials |
| NCT00003754 | Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00016861 | Irinotecan in Treating Children With Refractory or Progressive Solid Tumors | completed | Phase 1 | — | Texas Children's Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00513981 | High-Dose Methotrexate in Treating Young Patients With Solid Tumors | completed | Phase 1 | 36 | Children's Cancer and Leukaemia GroupOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00003630 | Arsenic Trioxide in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00068471 | Anidulafungin in Treating Immunocompromised Children With Neutropenia | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00004078 | Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 2 | 181 | Children's Oncology GroupNETWORK | 1 | Jun 14, 2013 | clinicaltrials |
| NCT00079404 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Feb 9, 2016source: clinicaltrials